➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Dow
Harvard Business School
Johnson and Johnson
Merck

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209430


Email this page to a colleague

« Back to Dashboard

NDA 209430 describes DAPSONE, which is a drug marketed by Taro, Taro Pharms, Actavis Llc, Alvogen, Jacobus, Nostrum Labs Inc, Novitium Pharma, Rising, and Virtus Pharms, and is included in eleven NDAs. It is available from eleven suppliers. Additional details are available on the DAPSONE profile page.

The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 209430
Tradename:DAPSONE
Applicant:Taro
Ingredient:dapsone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209430
Medical Subject Heading (MeSH) Categories for 209430
Suppliers and Packaging for NDA: 209430
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DAPSONE dapsone TABLET;ORAL 209430 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4197 51672-4197-2 2 BLISTER PACK in 1 CARTON (51672-4197-2) > 15 TABLET in 1 BLISTER PACK
DAPSONE dapsone TABLET;ORAL 209430 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4197 51672-4197-6 30 TABLET in 1 BOTTLE (51672-4197-6)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Mar 1, 2019TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Mar 1, 2019TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Johnson and Johnson
Merck
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.